Fennec Pharmaceuticals Inc. (FENC) - Stock Analysis

Last updated: Nov 19, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Q3 product sales rose 56%, the quarter was profitable and cash-flow positive, and shares gained about 28% through November 18; the extended price move warrants caution.

Loading chart data...

Idea window: 11/19/2026 – 11/26/2026Sector: Healthcare

AI Analyst Overview

Last Price
$13.09
Market Cap
$462.14M
1D Return
-2.68%
YTD Return
+70.00%

Loading chart data...

Valuation Metrics

P/E
571.6
P/B
9.3
P/S
7.0
EV/EBITDA
174.5
Div Yield
—

Idea History

DateCloseTickerCompanySummaryStatusP/L
Nov 19Nov 26FENCFennec Pharmaceuticals Inc.
Q3 product sales rose 56%, the quarter was profitable and cash-flow positive, and shares gained about 28% through November 18; the extended price move warrants caution.
Active+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.